The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
<p style="text-align:justify;"> <b> Background:</b> Establishing preclinical models is essential for novel drug discovery in schizophrenia. Most existing models are characterized by abnormalities in behavioral readouts, which are informative, but do not necessarily trans...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2012
|